Yemen Faces Severe Drug Shortages Amidst Saudi Aggression and Blockade

According to the International Desk of Webangah News Agency, Abdullah Al-Sharif, Deputy Head of Yemen‘s Supreme Pharmaceutical Affairs Committee, has emphasized the dire state of patients in Yemen, citing Saudi aggression and the ongoing blockade as the primary causes for a deficit of more than 1,600 essential drug types within the country. This situation has placed over 83 pharmaceutical companies, previously involved in supplying 1,300 types of medicines, in extremely precarious conditions.

The Saudi-American airstrikes targeting Yemen have also resulted in damage to two pharmaceutical production facilities. Al-Sharif highlighted that these aggressive actions have severely disrupted the supply chain for medicines entering Yemen. Furthermore, the blockade imposed by Saudi Arabia, coupled with the closure of Sana’a Airport, has led to a substantial increase in the cost of acquiring medications.

The repercussions of this crisis are particularly devastating for over 170,000 patients battling life-threatening conditions, including cancer. Their access to vital treatments has been critically compromised by the ongoing conflict and international restrictions.